Drug-drug Interaction (DDI) Rifabutin

Clinical trial NCT02138084 · COMPLETED

Trial details

NCT number: NCT02138084
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus

Start date: 2014-05-14
Primary completion: 2014-07-24
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.